About
Cost-effectiveness analysis is an odd preoccupation for a fertility doctor, and Dr. Nina Resetkova holds the two degrees that make it a formal one: she earned an M.D. and an M.B.A. together at Texas Tech University Health Sciences Center, the business degree specializing in health organization management. Her research applies that training to the questions patients are asked to decide without data: whether preimplantation genetic screening is worth its price for people with recurrent pregnancy loss — work selected for a prize oral presentation at the 2013 ASRM annual meeting — and, in a 2019 Human Reproduction paper, a practical framework for counselling patients on whether to test embryos at all. She also completed a research fellowship in the Harvard Department of Stem Cell and Reproductive Biology, using RNA sequencing to ask whether embryo gene expression predicts competence, published in Genome Research.
The other published strand in her work is family building for LGBTQ patients. The 2019 Fertility and Sterility paper comparing assisted reproduction outcomes between female-to-male transgender patients and cisgender patients carried two Boston IVF names in its author line, and one of them was hers; she co-authored it with Dr. Kim Thornton and the network’s embryology team, then followed it with a F S Reports commentary arguing that lesbian women’s path to pregnancy deserves a written best-practice standard of its own. For Resetkova this is not a referral category; it is published territory.
Born in Slovakia and raised in Toronto from a young age, she took a biochemistry degree with a management minor at McGill University before the combined M.D./M.B.A. at Texas Tech and a competitive OB/GYN residency at Johns Hopkins Hospital in Baltimore, where she served on the ethics and quality improvement committees and was elected Vice Chair of Communications on the House Staff Council. She is double board-certified in OB/GYN and REI and a Fellow of the American College of Obstetricians and Gynecologists, has held an executive role in the New England Fertility Society, and consults in person at Boston IVF’s Downtown Boston center, with telehealth across Massachusetts and Rhode Island. Her profile is carried on this Waltham page because the two centers are one network; the consult site published for her is downtown, and patients booking through Waltham should expect to be scheduled there or by telehealth.
Clinical Expertise
- LGBTQ+ family building: Reciprocal IVF, donor sperm, co-parenting arrangements and the counselling framework she helped propose in print
- Transgender fertility preservation: A co-author of the first comparative outcome study in this population
- PGT-A decision-making: Not whether testing is possible, but whether it pays off for a given patient — the subject of her award-selected cost-effectiveness research
- Recurrent pregnancy loss: Including genetic screening questions in the loss context
- Fertility preservation and exploration: Egg, embryo and sperm freezing for patients delaying or investigating
- IVF and ICSI: Cycle management with attention to obstetric outcomes after assisted conception
- Pregnancy complications after IVF: Her recent papers cover ischemic placental disease risk after donor oocytes and frozen transfer, and early beta-hCG as a marker
Why Choose Dr. Nina Resetkova
She has published the cost of the test you are being sold. Patients are rarely told whether PGT-A is worth its price for their specific situation; her prize-presented health-economics work and her Human Reproduction counselling framework are exactly that question.
An MBA inside the clinic. Health organization management training explains her interest in workflow and quality — and, for a patient, tends to show up as fewer loose ends between monitoring, retrieval and transfer.
She co-authored the transgender outcomes study. Fertility preservation counselling for a transgender patient usually runs on assumption; she has the primary data behind her advice.
Ethics committee training at Johns Hopkins. Residency years spent on ethics and quality improvement, plus elected house-staff leadership, in one of the country’s most competitive programs.
Two languages and three health systems. Slovak and English, with Canadian education, US residency and a Harvard research fellowship — relevant for international and immigrant families.
Professional Affiliations
Fellow of the American College of Obstetricians and Gynecologists; American Society for Reproductive Medicine; New England Fertility Society, where she served in an executive role. Double board-certified in Obstetrics and Gynecology and in Reproductive Endocrinology and Infertility.
Suitable For
- Lesbian couples planning reciprocal IVF: She has argued in print that this path needs a best-practice standard, and practises it
- Transgender patients freezing gametes: Counselling grounded in the comparative outcome study she co-authored
- Couples weighing whether to do PGT-A: The cost-effectiveness question is her published specialty, not a brochure decision
- Repeated miscarriage patients: Genetic screening and loss management are named research interests
- Rhode Island and Boston-area patients: In-person care downtown, telehealth in both states